Systemic delivery of ST317, a cell penetrating STING pathway sensitizer, results in strong anti-tumor activity
Claus Elsborg Olesen,Esben Axelgaard,Emil Nilsson,Anna H. Hansen,Isis Benoit-Lizon,Justin V. Joseph,Kristina Byskov,Magnus Strandh,Maja Myrcha,Pernille Rimmer Noer,Ulrich Sensfuss,Richard Charles Sainson,Richard C. Bethell,Martin R. Jakobsen
